Webinar: “Your confidential data: secure and treated with care”
In a world where personal information is increasingly valuable, protecting your health data is not optional: it is essential. We would like to invite you to the third webinar in a series of online events aimed at the general public, patients and people interested in neuromuscular diseases (European project CoMPaSS-NMD).
This webinar will be given by TECNALIA colleagues Ainara Garzo and Michael Obach, Medical Technologies researchers at TECNALIA and regulation and data experts.
Language: English (with simultaneous interpreting into Italian and German)
Not able to attend the live event? If you have signed up, you will receive the video to watch at any time.
Why are you interested in the webinar?
- Because your data tells your story and deserves to be treated with the utmost care.
What will you learn in this session?
- How we ensure the security and privacy of sensitive information.
- Measures we take to comply with European regulations.
- Innovative approaches such as federated learning, which enables you to move forward without compromising your privacy.
In this session, Ainara and Michael will discuss how sensitive health data is managed, and will explain the measures that are being taken to ensure its security and privacy, in compliance with European regulations. We will also talk about innovative approaches such as federated learning.
What is federated learning?
Federated learning is an AI technique where models are trained without centralising data. That is, instead of sending the data to a server, the model is trained locally on each device or institution and only the model parameters (not the original data) are shared.
This means:
- More privacy: sensitive data never leaves the place where it is generated.
- Regulatory compliance: it reduces the risk of exposure and complies with regulations such as the GDPR.
- Secure collaboration: hospitals, research centres and companies can work together without exchanging personal data.
This technique is especially useful in healthcare, where data protection is critical.
AI to help diagnose neuromuscular disorders
TECNALIA is taking part in “CoMPaSS-NMD - Computational Models for new Patients Stratification Strategies of Neuromuscular Disorders”, a project co-funded by the European Commission whose mission is to develop new, universal tools for more accurate and personalised diagnosis, monitoring and treatment of patients affected by hereditary neuromuscular diseases.
- Using advanced clustering techniques, CoMPaSS-NMD will identify groups of patients with similar clinical characteristics. These pathologies often affect young people and can cause long-term disability and premature death.
- The initiative, coordinated by Rossella Tupler, medical geneticist at the University of Modena, involves six clinical centres (biotech, ICT, AI, ethical and legal) in Italy, France, Germany, Finland and the UK, and four industrial partners (including TECNALIA), many of which are present in the framework of the European reference network for rare neurological diseases.
TECNALIA works to anticipate the challenges of the future, developing solutions that combine innovation and trust. This webinar reflects our commitment to secure and responsible data management, because we believe that technology should work for people.